Astera Labs (NASDAQ:ALAB) Stock Falls 3.7% - Here's Why

Key Points

• Astera Labs shares fell 3.7% to $351.31, with trading volume below its average. The stock has a $60.95 billion market capitalization and a high beta of 3.77, indicating significant volatility.
• Despite the decline, recent quarterly results exceeded expectations: EPS was $0.80 versus the $0.69 consensus, while revenue rose 104.5% year over year to $392.4 million. Analysts maintain a “Moderate Buy” consensus, with an average price target of $348.33.
• Insiders have sold approximately $209.5 million worth of shares over the past 90 days, while institutional investors own 60.47% of the company. Amazon also acquired a new stake valued at roughly $134.2 million.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) was down 3.7% on Monday. The stock traded as low as $342.00 and last traded at $351.31. Approximately 4,064,165 shares traded hands during mid-day trading, a decline of 22% from the average session volume of 5,230,728 shares. The stock had previously closed at $364.62.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Needham & Company LLC raised their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Barclays upped their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research report on Monday, July 20th. Morgan Stanley increased their price target on Astera Labs to $335.00 and gave the company an "overweight" rating in a research note on Monday, August 3rd. Citigroup restated a "buy" rating on shares of Astera Labs in a research report on Wednesday, July 29th. Finally, Stifel Nicolaus lifted their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Astera Labs currently has an average rating of "Moderate Buy" and an average target price of $348.33.

Astera Labs Stock Performance

The business's 50-day moving average is $305.17 and its two-hundred day moving average is $274.90. The firm has a market capitalization of $60.95 billion, a price-to-earnings ratio of 173.92 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same quarter in the previous year, the company earned $0.44 earnings per share. The business's revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Buying and Selling

In other news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director owned 253,863 shares of the company's stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the company's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company's stock, valued at approximately $32,872,551. This represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 591,558 shares of company stock worth $209,458,976 over the last ninety days. Insiders own 10.40% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ALAB. Eurizon Capital SGR S.p.A. acquired a new stake in Astera Labs during the 4th quarter worth approximately $18,708,000. Banque Cantonale Vaudoise boosted its holdings in shares of Astera Labs by 85.9% in the first quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company's stock valued at $766,000 after buying an additional 3,229 shares during the period. Prudential PLC boosted its holdings in shares of Astera Labs by 51.7% in the fourth quarter. Prudential PLC now owns 62,790 shares of the company's stock valued at $10,446,000 after buying an additional 21,390 shares during the period. Nomura Asset Management Co. Ltd. increased its position in shares of Astera Labs by 63.7% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 473,179 shares of the company's stock worth $78,718,000 after acquiring an additional 184,113 shares in the last quarter. Finally, Amazon Com Inc. bought a new stake in shares of Astera Labs during the second quarter worth $134,172,000. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company's portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.